期刊
BIOMARKERS
卷 19, 期 3, 页码 222-230出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/1354750X.2014.897757
关键词
Acetaminophen; diagnosis; hepatotoxicity; mitochondria; prognosis
资金
- McNeil Consumer Health, Inc.
- University of Kansas Medical Center Liver Center
- National Institutes of Health [R01 DK070195, R01 AA12916, R44 DK074205]
- National Center for Research Resources [5P20RR021940-07]
- National Institute of General Medical Sciences of the National Institutes of Health [8 P20 GM103549-07]
- Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20 GM12345]
- National Institute of Environmental Health Sciences [T32 ES007079-26A2]
Context: New biomarkers are needed in acetaminophen (APAP) hepatotoxicity. Plasma argininosuccinate synthetase (ASS) is a promising candidate. Objective: Characterize ASS in APAP hepatotoxicity. Methods: ASS was measured in plasma from rodents and humans with APAP hepatotoxicity. Results: In mice, ASS increased before injury, peaked before alanine aminotransferase (ALT) and decreased rapidly. Fischer rats had a greater increase in ASS relative to ALT. Patients with abnormal liver test results had very high ASS compared to controls. ASS appeared to increase early in some patients, and declined rapidly in all. Conclusions: ASS may be a useful biomarker of acute cell death in APAP hepatotoxicity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据